Heroin Addiction-Marks et al.
Recently it has been our practice, particularly with younger patients, to use the nalorphine test when it is required urgently to know whether the patient is or is not " hooked on " heroin. A positive test is one in which there is a paradoxical pupil response-that is, one in which the pupils enlarge significantly within half an hour of the injection of 4 mg. of nalorphine subcutaneously. For the purpose of objective measurement, the response is recorded by means of a Polaroid camera, fitted with a pupillometer adapter. Severe reactions to this dose of nalorphine are rare, but should one occur it can readily be relieved by intravenous methadone. Despite the advantage of speed, the nalorphine test is not altogether satisfactory in practice, largely because of its non-specificity and the high incidence of both false-positive and false-negative results.
It is our belief that, provided the work-load justifies the employment of adequate technical and capital resources, the results of a qualitative urine analysis which does not possess the disadvantages of the nalorphine test can be returned to clinicians within 24 hours of receipt of the specimen, and in special cases in as little as five hours.
(2) Possession of objective data by the clinician in place of his complete dependence on the patient's history helps strengthen the doctor-patient relationship. The strength of this bond depends largely on the respect the doctor is able to command from his patient. It is particularly important in the type of patient under discussion, who frequently looks on the doctor as a " dupe" or " square" whose main function is to dispense drugs on demand.
(3) Clinical interpretation of the results of urine analysis may be difficult. Currently there are no methods suitable for detecting morphine in blood routinely; and quantitative measurements of morphine in urine are tedious and for various reasons offer no advantage over qualitative determination (Marks, 1966) .
Technically it may not always be possible to identify morphine in the urine when it is present in small amounts. Not only may the quantity present be less than the sensitivity of the method (about 1 /ig./ml.), but the presence in the urine of other drugs, or more often their metabolites in high concentration, may serve to obscure what little there is. The phenothiazines and the substitute narcotic methadone are particularly important in this respect. It is largely because these drugs are so often used in the treatment of heroin addiction that we have not found simpler methods of urine analysis for morphine (Harms, 1965 ; Davidow et al., 1966 ) satisfactory in our laboratory.
Clinically it is difficult or impossible to distinguish by urine analysis a large dose of heroin administered a long time previously from a small amount taken recently. Nor is it possible to distinguish heroin from morphine. Moreover, absence of morphine from the urine is not conclusive evidence that the subject has not taken heroin ; only that, if taken, the dose was too small or too long ago to be detectable. In practice a negative result generally means that less than 10 mg. of heroin has been taken in the past 24 hours. Consequently, a negative result in a patient who does not exhibit abstinence syndrome is good evidence against physical (though not necessary psychic) dependence on the drug. It must be remembered that urine morphine may originate either from heroin or morphine, though currently only the former drug is affected by the recent restriction on prescribing narcotics for addicts. Morphine also occurs in the urine, though only in the bound or conjugated form, of persons taking codeine owing to partial metabolic conversion in the body. This should not give rise to confusion in practice, as codeine is also prescnt in large amounts and is readily detectable on the thin-layer chromatographic plate. 
Introduction
Trasicor is a b-ta-adrenergic blocking agent which has recently been introduced by Ciba. A haemodynamic investigation of its effects showed that rapid intravenous injection of 5 mg. produced negative chronotropic and negative inotropic effects.
In contrast, prolonged oral therapy with Trasicor produced a negative chronotropic and a positive inotropic effect, with a marked increase in stroke volume . Studies showed that the beta-blocker propranolol produced similar results when given intravenously, but the effects of long-term oral therapy appeared to be due solely to a negative chronotropic action, there being no change in stroke volume (Frohlich et al., 1968) .
A single-blind trial with Trasicor in nine patients with angina pectoris showed that the drug significantly reduced the number of angina attacks and that there were few side-effects (Wilson and Turner, 1967 The patients who were admitted to the trial had suffered at least two attacks of angina pectoris each week before the beginning of Trasicor therapy. The pains were typical in character and distribution and were relieved by glyceryl trinitrate tablets. Nineteen patients entered the trial, which was controlled by a single clinician. The general purpose of the trial was explained to patients and they were told that various " strengths " of the drug were being assessed. In addition, they were instructed to consult an independent medical referee-a physician not otherwise connected with the trialshould untoward symptoms arise. This precaution was taken following the experience in our single-blind trial in which three patients had to be admitted to hospital with acute coronary insufficiency when Trasicor was abruptly stopped.
Assessment
At the beginning of the trial each patient was allocated a trial number and a brief history was recorded. Each was given a known number of glyceryl trinitrate tablets and told to take them for actual pain and not as a prophylactic. For each period of the trial the patient was asked to record each day, on the sheet supplied, the daily number and severity of angina attacks, the number of glyceryl trinitrate tablets taken, any side-effects noted, and a subjective assessment of the treatment for that particular period. He was then given a prescription indicating the number of " Trasicor " tablets to be supplied. This was presented to the pharmacist involved in the trial, who supplied the requisite number of tablets for the next period.
The medical referee found it necessary to break the code in connexion with those patients he had to withdraw from the trial. The trial was so planned that, apart from this, no one knew whether the drug or placebo was being taken until after the trial series had been completed.
BRTSH MEDICAL JOURNAL Results
The results are shown in the resorted to glyceryl trinitrate for every attack of angina pectoris. Even in those cases that had to be withdrawn from the trial the consumption of glyceryl trinitrate tablets in 24 hours was often of the order of one to three tablets. Patients limited their intake of glyceryl trinitrate for two reasons: they objected to "taking too many tablets" and the headache following glyceryl trinitrate was often extremely unpleasant. Relief from pain was obtained by a restriction of activity. These findings differ markedly from those of many similar trials of drugs in the treatment of angina pectoris. Gillman and Prichard (1965) found a close correlation between glyceryl trinitrate consumption and angina attacks when working with propranolol.
Case 5 illustrates another aspect of the importance of the qualitative approach. When taking placebo this patient was confined to the house, physical activity was severely limited, and the slightest exertion precipitated his angina. On Trasicor therapy effort tolerance was greatly improved, so that pains were experienced and glyceryl trinitrate was taken only after severe exertion. Such marked improvement when on Trasicor therapy is not apparent from the Table, which depicts quantitative results only.
It is our bpinion that in a trial of this nature more emphasis should be placed on qualitative results than has been customary in the past, as quantitative results can be misleading.
The abrupt replacement of Trasicor with placebo resulted in severe exacerbation of angina in seven patients, six of whom had to be withdrawn from the trial. This did not appear to be related to the dosage of the drug, which varied from 60 to 340 mg. daily in these cases. Perhaps the patients had become accustomed to a higher level of effort tolerance which could not be maintained once the Trasicor was discontinued. However, this does not appear to be the complete answer, as three patients suffered frequent angina attacks at rest and on effort for several days before reporting to the medical referee. Perhaps, in addition, there is some form of protracted " rebound " release of sympathetic drive when Trasicor is stopped abruptly. This finding suggests that caution should be exercised when stopping Trasicor in angina patients and that probably a count-down method should be used.
Patients who completed the trial commented on their sense of well-being and improved exercise tolerance during the Trasicor treatment periods. This contrasts with the mental depression reported following the use of propranolol (Waal, 1967) . This may be explained by the difference in the haemodynamic effects of the two drugs .
We found that old age was no contraindication to Trasicor therapy and that large doses were well tolerated. One All this previous work had been carried out in animals, but in view of these findings we decided to investigate the effect of polypeptide ACG on the hyperglycaemia of patients suffering from diabetes mellitus.
PRESENT INVESTIGATION
Techniques.-Polypeptide ACG was prepared from ovine growth hormone according to the technique previously described (Bornstein et al., 1968b) and sterilized for use by ultrafiltration. The yield was 5 mg. from 2 g. of growth hormone, representing 500 g. wet weight of ovine pituitaries. The activity of each preparation was assayed by its ability to reverse the inhibition of glyceraldehyde-3-phosphate dehydrogenase produced by a standard concentration of ING. Blood glucose estimations were done by Dr. J. Owen, of the Biochemistry Department, Alfred Hospital, using the standard AutoAnalyzer technique. Plasma insulin estimations were done by using a modification of the double antibody immunoassay technique of Morgan and Lazarow (1963) . The coefficient of variation of the method of a plasma pool containing 24 pu./ml. was 8%.
